NCT06551818View on ClinicalTrials.gov

A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

March 2, 2025

Study Completion Date

March 2, 2025

Conditions
Androgenic Alopecia
Interventions
OTHER

SesZen-Bio Low Dose 1 (350 mg extract)

"Mode of Usage: Swallow the capsule whole with a full glass of water without chewing, crushing, or opening it.~Dosage form: Capsule Frequency: One time daily after meal Rout of administration: Oral"

OTHER

SesZen-Bio Low Dose 1 (150 mg liposomal)

"Mode of Usage: Swallow the capsule whole with a full glass of water without chewing, crushing, or opening it.~Dosage form: Capsule Frequency: One time daily after meal Rout of administration: Oral"

OTHER

SesZen-Bio High Dose 1 (500 mg extract)

"Mode of Usage: Swallow the capsule whole with a full glass of water without chewing, crushing, or opening it.~Dosage form: Capsule Frequency: One time daily after meal Rout of administration: Oral"

OTHER

Placebo

"Mode of Usage: Swallow the capsule whole with a full glass of water without chewing, crushing, or opening it.~Dosage form: Capsule Frequency: One time daily after meal Rout of administration: Oral"

All Listed Sponsors
collaborator

Zywie Ventures Privated Ltd

UNKNOWN

lead

NovoBliss Research Pvt Ltd

OTHER

NCT06551818 - A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III). | Biotech Hunter | Biotech Hunter